Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells. [GOC:mah]
Positive regulation of cellular biosynthetic process is a fundamental biological process that governs the rate and efficiency of biosynthesis within cells. It involves a complex interplay of regulatory mechanisms that fine-tune the production of essential cellular components, such as proteins, lipids, carbohydrates, and nucleic acids. This intricate process is crucial for maintaining cellular homeostasis, responding to environmental cues, and driving cellular growth and differentiation.
The regulation of biosynthesis encompasses a wide range of mechanisms, including:
**Transcriptional Regulation:** The initiation of biosynthesis is tightly controlled at the level of gene expression. Transcription factors, specific proteins that bind to DNA, can activate or repress the transcription of genes encoding biosynthetic enzymes. These factors are influenced by various intracellular and extracellular signals, including nutrient availability, growth factors, and stress responses.
**Post-Transcriptional Regulation:** Once mRNA is transcribed, it can be subjected to further regulation. MicroRNAs (miRNAs), small non-coding RNA molecules, can bind to target mRNAs and regulate their stability and translation. This regulation can fine-tune the production of biosynthetic enzymes, ensuring that their levels are appropriate for cellular needs.
**Post-Translational Regulation:** After protein synthesis, biosynthetic enzymes can be further regulated by post-translational modifications. These modifications include phosphorylation, acetylation, and ubiquitination, which can alter the activity, localization, and stability of enzymes. This dynamic regulation allows cells to rapidly respond to changing environmental conditions.
**Metabolic Regulation:** The activity of biosynthetic pathways is also influenced by the availability of substrates and the levels of metabolic intermediates. For example, the availability of amino acids is crucial for protein synthesis, while the levels of glucose and fatty acids affect the production of carbohydrates and lipids.
**Feedback Regulation:** Biosynthetic pathways often exhibit feedback regulation, where the end product of a pathway inhibits an earlier step. This negative feedback loop prevents the overproduction of unnecessary metabolites and ensures that resources are allocated efficiently.
**Signal Transduction:** Extracellular signals, such as growth factors and hormones, can trigger intracellular signaling pathways that ultimately regulate biosynthesis. These pathways involve a cascade of protein interactions and modifications, culminating in the activation or repression of transcription factors or enzymes involved in biosynthesis.
The positive regulation of cellular biosynthetic process is essential for various cellular functions, including:
* **Growth and Development:** Biosynthesis is crucial for the production of new cells and tissues, enabling growth and development.
* **Response to Stress:** Cells can activate biosynthetic pathways in response to stress, such as nutrient deprivation or infection, to produce essential molecules for survival and repair.
* **Cellular Differentiation:** Biosynthetic pathways play a key role in the differentiation of cells into specialized types, enabling the formation of diverse tissues and organs.
* **Adaptation to Environmental Changes:** Cells can adjust their biosynthetic activities in response to changing environmental conditions, ensuring that they can adapt to new challenges.
In summary, positive regulation of cellular biosynthetic process is a highly intricate and dynamic process that involves multiple levels of regulation, from gene expression to post-translational modifications. This complex interplay ensures that biosynthesis is tightly controlled, allowing cells to maintain homeostasis, respond to environmental cues, and execute essential cellular functions.'
"
Protein | Definition | Taxonomy |
---|---|---|
Interleukin-8 | An interleukin-8 that is encoded in the genome of human. [PMID:15623624, SALO:AJ] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
diclofenac | diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position. Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
indomethacin | indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis. Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic; xenobiotic metabolite |
tolmetin | tolmetin : A monocarboxylic acid that is (1-methylpyrrol-2-yl)acetic acid substituted at position 5 on the pyrrole ring by a 4-methylbenzoyl group. Used in the form of its sodium salt dihydrate as a nonselective nonsteroidal anti-inflammatory drug. Tolmetin: A non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL) similar in mode of action to INDOMETHACIN. | aromatic ketone; monocarboxylic acid; pyrroles | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug |
ibufenac | ibufenac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 4-isobutylphenyl group. Although it was shown to be effective in treatment of rheumatoid arthritis, the clinical use of ibufenac was discontinued due to hepatotoxic side-effects. ibufenac: used in the treatment of rheumatism; also possesses antipyretic properties; minor descriptor (75-84); on-line & Index Medicus search PHENYLACETATES (75-84); RN given refers to parent cpd | monocarboxylic acid | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; hepatotoxic agent; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
ibuprofen, (r)-isomer | ibuprofen | ||
ketoprofen | |||
2-anilinophenylacetic acid | 2-anilinophenylacetic acid: structure in first source |